ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 927,62
0,44%
Dow Jones
44 400,13
-0,37%
DAX
21 394,93
-0,11%
Brent Oil
77,675
0,45%
Bitcoin
106 410,37
2,35%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. ETFs
  4. Royaume-Uni
  5. LSE
  6. Ls 2x Salesforc (CRME)

  7. Ls 2x Salesforc (CRME) Actualités

CRME

Ls 2x Salesforc (CRME)

Ls 2x Salesforc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:CRME
DateHeureSourceTitreSymboleSociété
24/04/202316h47UK RegulatoryLeverage Shares PLC Issuer Call Redemption ConfirmationLSE:CRMELs 2x Salesforc
21/12/200923h05PR Newswire (US)Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase PlansLSE:CRME
18/12/200900h00PR Newswire (US)Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator StudyLSE:CRME
09/11/200914h40PR Newswire (US)Cardiome Reports Third Quarter ResultsLSE:CRME
07/11/200900h00PR Newswire (US)Cardiome to Release Third Quarter ResultsLSE:CRME
02/11/200920h35PR Newswire (US)Cardiome To Present At Oppenheimer Healthcare ConferenceLSE:CRME
28/10/200921h58PR Newswire (US)Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 TrialLSE:CRME
17/10/200902h54PR Newswire (US)Cardiome Pharma Corp. Announces Final Results of Tender OfferLSE:CRME
14/10/200912h00PR Newswire (US)Cardiome Pharma Corp. Announces Preliminary Results of Tender OfferLSE:CRME
01/09/200920h57PR Newswire (US)Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender OfferLSE:CRME
28/08/200919h30PR Newswire (US)Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of LSE:CRME
25/08/200923h11PR Newswire (US)Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common SharesLSE:CRME
11/08/200913h45PR Newswire (US)Cardiome Reports Second Quarter ResultsLSE:CRME
11/08/200901h45PR Newswire (US)Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol AgreementLSE:CRME
10/08/200922h35PR Newswire (US)Cardiome to Hold Conference CallLSE:CRME
03/08/200923h16PR Newswire (US)Cardiome Announces Management TransitionLSE:CRME
28/07/200917h45PR Newswire (US)Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.LSE:CRME
19/05/200914h30PR Newswire (US)Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now EffectiveLSE:CRME
15/05/200922h05PR Newswire (US)Cardiome Reports First Quarter ResultsLSE:CRME
28/11/200823h31PR Newswire (US)Cardiome Discloses Chairman And CEO's Involuntary Share SaleLSE:CRME
24/10/200804h40PR Newswire (US)Cardiome Announces Filing Of Shelf Registration StatementLSE:CRME
09/10/200818h20PR Newswire (US)Cardiome Provides Regulatory UpdateLSE:CRME
11/08/200822h30PR Newswire (US)Cardiome to Release Second Quarter Results and Hold Conference CallLSE:CRME
11/08/200815h18PR Newswire (US)Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)LSE:CRME
23/07/200820h10PR Newswire (US)Cardiome Announces Preferred Share FinancingLSE:CRME
14/07/200814h25PR Newswire (US)Cardiome Announces Positive Phase 2b Results For Oral VernakalantLSE:CRME
13/07/200818h00PR Newswire (US)Cardiome To Hold Conference CallLSE:CRME
03/06/200811h32PR Newswire (US)K I L L K I L L K I L L -- Cardiome Pharma Corp.LSE:CRME
28/05/200822h25PR Newswire (US)TEST - Jay 14 - Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as StrategicLSE:CRME
12/05/200823h45PR Newswire (US)Cardiome To Release 2008 First Quarter ResultsLSE:CRME
 Showing the most relevant articles for your search:LSE:CRME

Dernières Valeurs Consultées

COIN
BTCUSD
Bitcoin
EU
BNP
BNP Paribas
NASDAQ
NVDA
NVIDIA
EU
CS
Axa
NYSE
DIS
Walt Disney
EU
ORA
Orange
NYSE
JPM
JP Morgan Chase
EU
EN
Bouygues
EU
GLE
Societe Generale
EU
RNO
Renault
COIN
AVAXUSD
Avalanche
COIN
XRPUSD
Ripple
EU
VIV
Vivendi
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés